1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Application Analysis
3.8 Emerging Markets
3.9 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Nanomedicine Market, By Product Type
5.1 Introduction
5.2 Nanoparticles
5.2.1 Metal & Metal Oxide Nanoparticles
5.2.2 Liposomes
5.2.3 Polymers & Polymer Drug Conjugates
5.2.4 Hydrogel Nanoparticles
5.2.5 Dendrimers
5.2.6 Inorganic Nanoparticles
5.3 Nano Tubes
5.4 Nano Devices
5.5 Nano Shells
5.6 Other Product Types
6 Global Nanomedicine Market, By Modality
6.1 Introduction
6.2 Treatment
6.3 Diagnostics
7 Global Nanomedicine Market, By Indication
7.1 Introduction
7.2 Clinical Oncology
7.3 Infectious Diseases
7.4 Clinical Cardiology
7.5 Urology
7.6 Ophthalmology
7.7 Immunology
7.8 Cardiovascular Diseases
7.9 Orthopedic Diseases
7.10 Neurological Diseases
7.11 Anti-Inflammatory Diseases
7.12 Anti-Infective Diseases
7.13 Other Indications
8 Global Nanomedicine Market, By Application
8.1 Introduction
8.2 Drug Delivery
8.3 Diagnostic Imaging
8.4 In vitro Diagnostics
8.5 Implants
8.6 Regenerative Medicine
8.7 Vaccines
8.8 In-Vitro Imaging
8.9 Therapeutics
8.10 In-vivo Imaging
8.11 Other Applications
9 Global Nanomedicine Market, By Geography
9.1 Introduction
9.2 North America
9.2.1 US
9.2.2 Canada
9.2.3 Mexico
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 Italy
9.3.4 France
9.3.5 Spain
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 New Zealand
9.4.6 South Korea
9.4.7 Rest of Asia Pacific
9.5 South America
9.5.1 Argentina
9.5.2 Brazil
9.5.3 Chile
9.5.4 Rest of South America
9.6 Middle East & Africa
9.6.1 Saudi Arabia
9.6.2 UAE
9.6.3 Qatar
9.6.4 South Africa
9.6.5 Rest of Middle East & Africa
10 Key Developments
10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies
11 Company Profiling
11.1 NanoCarrier Co. Ltd
11.2 Sanofi SA
11.3 Leadient BioSciences Inc.
11.4 Celgene Corporation
11.5 Abbott Laboratories
11.6 CombiMatrix Corporation
11.7 Johnson & Johnson Services Inc
11.8 Mallinckrodt Pharmaceuticals
11.9 Nanobiotix
11.10 Merck & Co., Inc.
11.11 Nanospectra Biosciences, Inc.
11.12 Gilead Sciences, Inc.
11.13 Arrowhead Pharmaceuticals, Inc.
11.14 Novavax, Inc.
11.15 Pfizer, Inc.
11.16 Teva Pharmaceutical Industries Ltd.
11.17 GE Healthcare
11.18 Taiwan Liposome Company Ltd
11.19 Genzyme Corporation
List of Tables
Table 1 Global Nanomedicine Market Outlook, By Region (2021-2030) ($MN)
Table 2 Global Nanomedicine Market Outlook, By Product Type (2021-2030) ($MN)
Table 3 Global Nanomedicine Market Outlook, By Nanoparticles (2021-2030) ($MN)
Table 4 Global Nanomedicine Market Outlook, By Metal & Metal Oxide Nanoparticles (2021-2030) ($MN)
Table 5 Global Nanomedicine Market Outlook, By Liposomes (2021-2030) ($MN)
Table 6 Global Nanomedicine Market Outlook, By Polymers & Polymer Drug Conjugates (2021-2030) ($MN)
Table 7 Global Nanomedicine Market Outlook, By Hydrogel Nanoparticles (2021-2030) ($MN)
Table 8 Global Nanomedicine Market Outlook, By Dendrimers (2021-2030) ($MN)
Table 9 Global Nanomedicine Market Outlook, By Inorganic Nanoparticles (2021-2030) ($MN)
Table 10 Global Nanomedicine Market Outlook, By Nano Tubes (2021-2030) ($MN)
Table 11 Global Nanomedicine Market Outlook, By Nano Devices (2021-2030) ($MN)
Table 12 Global Nanomedicine Market Outlook, By Nano Shells (2021-2030) ($MN)
Table 13 Global Nanomedicine Market Outlook, By Other Product Types (2021-2030) ($MN)
Table 14 Global Nanomedicine Market Outlook, By Modality (2021-2030) ($MN)
Table 15 Global Nanomedicine Market Outlook, By Treatment (2021-2030) ($MN)
Table 16 Global Nanomedicine Market Outlook, By Diagnostics (2021-2030) ($MN)
Table 17 Global Nanomedicine Market Outlook, By Indication (2021-2030) ($MN)
Table 18 Global Nanomedicine Market Outlook, By Clinical Oncology (2021-2030) ($MN)
Table 19 Global Nanomedicine Market Outlook, By Infectious Diseases (2021-2030) ($MN)
Table 20 Global Nanomedicine Market Outlook, By Clinical Cardiology (2021-2030) ($MN)
Table 21 Global Nanomedicine Market Outlook, By Urology (2021-2030) ($MN)
Table 22 Global Nanomedicine Market Outlook, By Ophthalmology (2021-2030) ($MN)
Table 23 Global Nanomedicine Market Outlook, By Immunology (2021-2030) ($MN)
Table 24 Global Nanomedicine Market Outlook, By Cardiovascular Diseases (2021-2030) ($MN)
Table 25 Global Nanomedicine Market Outlook, By Orthopedic Diseases (2021-2030) ($MN)
Table 26 Global Nanomedicine Market Outlook, By Neurological Diseases (2021-2030) ($MN)
Table 27 Global Nanomedicine Market Outlook, By Anti-Inflammatory Diseases (2021-2030) ($MN)
Table 28 Global Nanomedicine Market Outlook, By Anti-Infective Diseases (2021-2030) ($MN)
Table 29 Global Nanomedicine Market Outlook, By Other Indications (2021-2030) ($MN)
Table 30 Global Nanomedicine Market Outlook, By Application (2021-2030) ($MN)
Table 31 Global Nanomedicine Market Outlook, By Drug Delivery (2021-2030) ($MN)
Table 32 Global Nanomedicine Market Outlook, By Diagnostic Imaging (2021-2030) ($MN)
Table 33 Global Nanomedicine Market Outlook, By In vitro Diagnostics (2021-2030) ($MN)
Table 34 Global Nanomedicine Market Outlook, By Implants (2021-2030) ($MN)
Table 35 Global Nanomedicine Market Outlook, By Regenerative Medicine (2021-2030) ($MN)
Table 36 Global Nanomedicine Market Outlook, By Vaccines (2021-2030) ($MN)
Table 37 Global Nanomedicine Market Outlook, By In-Vitro Imaging (2021-2030) ($MN)
Table 38 Global Nanomedicine Market Outlook, By Therapeutics (2021-2030) ($MN)
Table 39 Global Nanomedicine Market Outlook, By In-vivo Imaging (2021-2030) ($MN)
Table 40 Global Nanomedicine Market Outlook, By Other Applications (2021-2030) ($MN)
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
